Perioperative myocardial ischemia and infarction are not only major sources of morbidity and mortality in patients undergoing surgery but also important causes of prolonged hospital stay and resource utilization. Ischemic and pharmacological preconditioning and postconditioning have been known for more than two decades to provide protection against myocardial ischemia and reperfusion and limit myocardial infarct size in many experimental animal models, as well as in clinical studies (1-3). This paper will review the physiology and pharmacology of ischemic and drug-induced preconditioning and postconditioning of the myocardium with special emphasis on the mechanisms by which volatile anesthetics provide myocardial protection. Insights gained from animal and clinical studies will be presented and reviewed and recommendations for the use of perioperative anesthetics and medications will be given.
Murry CE, Jennings RB, Reimer KAPreconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium . Circulation. 1986;74:1124-1136.
2.
Yellon DM, Downey JMPreconditioning the myocardium: from cellular physiology to clinical cardiology . Physiol Rev. 2003;83:1113-1151.
3.
Marber MS, Latchman DS, Walker JM, Yellon DMCardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation . 1993;88:1264-1272.
4.
Hausenloy DJ , Tsang A., Mocanu MM, Yellon DMIschemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol. 2005;288: H971-H976.
5.
Raphael J., Zuo Z., Abedat S., Beeri R., Gozal Y.Isoflurane preconditioning decreases myocardial infarction in rabbits via up-regulation of hypoxia inducible factor 1 that is mediated by mammalian target of rapamycin. Anesthesiology. 2008;108:415-425.
6.
Garlid KD, Paucek P., Yarov-Yarovoy V., et al. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection . Circ Res. 1997;81:1072-1082.
7.
Raphael J., Drenger B., Rivo J., Berenshtein E., Chevion M., Gozal Y.Ischemic preconditioning decreases the reperfusion-related formation of hydroxyl radicals in a rabbit model of regional myocardial ischemia and reperfusion: the role of K(ATP) channels. Free Radic Res. 2005;39:747-754.
8.
Vanden Hoek TL, Becker LB, Shao Z., Li C., Schumacker PTReactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem. 1998;273:18092-18098.
9.
Hausenloy DJ , Maddock HL, Baxter GF, Yellon DMInhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res. 2002;55:534-543.
10.
Reiz S., Balfors E., Sorensen MB, Ariola S. Jr, Friedman A., Truedsson H.Isoflurane-a powerful coronary vasodilator in patients with coronary artery disease. Anesthesiology. 1983; 59:91-97.
11.
Becker LCIs isoflurane dangerous for the patient with coronary artery disease? Anesthesiology. 1987;66:259-261.
12.
Moore PG, Kien ND, Reitan JA, White DA, Safwat AMNo evidence for blood flow redistribution with isoflurane or halothane during acute coronary artery occlusion in fentanylanesthetized dogs. Anesthesiology. 1991;75:854-865.
13.
Pulley DD, Kirvassilis GV, Kelermenos N., et al. Regional and global myocardial circulatory and metabolic effects of isoflurane and halothane in patients with steal-prone coronary anatomy . Anesthesiology. 1991;75:756-766.
14.
Diana P., Tullock WC, Gorcsan J. 3rd, Ferson PF, Arvan S.Myocardial ischemia: a comparison between isoflurane and enflurane in coronary artery bypass patients. Anesth Analg. 1993 ;77:221-226.
15.
Tanaka K., Ludwig LM, Kersten JR, Pagel PS, Warltier DCMechanisms of cardioprotection by volatile anesthetics. Anesthesiology . 2004;100:707-721.
16.
Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DCIsoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology. 1997;87:361-370.
17.
Ludwig LM, Patel HH, Gross GJ, Kersten JR, Pagel PS, Warltier DCMorphine enhances pharmacological preconditioning by isoflurane: role of mitochondrial K(ATP) channels and opioid receptors. Anesthesiology. 2003;98:705-711.
18.
Cason BA, Gamperl AK, Slocum RE, Hickey RFAnesthetic-induced preconditioning: previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology . 1997;87:1182-1190.
19.
Maxwell MP, Hearse DJ, Yellon DMSpecies variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res. 1987;21:737-746.
20.
Zaugg M., Lucchinetti E., Spahn DR, Pasch T., Schaub MCVolatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial K(ATP) channels via multiple signaling pathways. Anesthesiology. 2002;97:4-14.
21.
Tanaka K., Ludwig LM, Krolikowski JG, et al. Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2. Anesthesiology. 2004;100:525-531.
22.
de Klaver MJ , Buckingham MG, Rich GFIsoflurane pretreatment has immediate and delayed protective effects against cytokine-induced injury in endothelial and vascular smooth muscle cells. Anesthesiology. 2003;99:896-903.
23.
Toller WG, Kersten JR, Pagel PS, Hettrick DA, Warltier DCSevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Anesthesiology. 1999;91:1437-1446.
24.
Mullenheim J., Ebel D., Bauer M., et al. Sevoflurane confers additional cardioprotection after ischemic late preconditioning in rabbits. Anesthesiology . 2003;99:624-631.
25.
Cason BA, Shubayev I., Hickey RFBlockade of adenosine triphosphate-sensitive potassium channels eliminates isoflurane-induced coronary artery vasodilation. Anesthesiology . 1994; 81:1245-1255.
26.
Kersten JR, Schmeling T., Tessmer J., Hettrick DA, Pagel PS, Warltier DCSevoflurane selectively increases coronary collateral blood flow independent of KATP channels in vivo. Anesthesiology. 1999;90:246-256.
27.
Novalija E. , Fujita S., Kampine JP, Stowe DFSevoflurane mimics ischemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts. Anesthesiology. 1999;91:701-712.
28.
Kowalski C. , Zahler S., Becker BF, et al. Halothane, isoflurane, and sevoflurane reduce postischemic adhesion of neutrophils in the coronary system. Anesthesiology. 1997;86:188-195.
29.
de Klaver MJ , Manning L., Palmer LA, Rich GFIsoflurane pretreatment inhibits cytokine-induced cell death in cultured rat smooth muscle cells and human endothelial cells . Anesthesiology. 2002;97:24-32.
30.
Raphael J., Abedat S., Rivo J., et al. Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via Akt signaling and modulation of Bcl-2 family proteins. J Pharmacol Exp Ther. 2006;318:186-194.
31.
Jamnicki-Abegg M., Weihrauch D., Pagel PS, et al. Isoflurane inhibits cardiac myocyte apoptosis during oxidative and inflammatory stress by activating Akt and enhancing Bcl-2 expression. Anesthesiology. 2005;103:1006-1014.
32.
Kersten JR, Orth KG, Pagel PS, Mei DA, Gross GJ, Warltier DCRole of adenosine in isoflurane-induced cardioprotection. Anesthesiology. 1997;86:1128-1139.
33.
Roscoe AK, Christensen JD, Lynch C. 3rd.Isoflurane, but not halothane, induces protection of human myocardium via adenosine A1 receptors and adenosine triphosphate-sensitive potassium channels . Anesthesiology. 2000;92:1692-1701.
34.
Cope DK, Impastato WK, Cohen MV, Downey JMVolatile anesthetics protect the ischemic rabbit myocardium from infarction . Anesthesiology. 1997;86:699-709.
35.
Toller WG, Kersten JR, Gross ER, Pagel PS, Warltier DCIsoflurane preconditions myocardium against infarction via activation of inhibitory guanine nucleotide binding proteins. Anesthesiology. 2000;92:1400-1407.
36.
Mullenheim J., Ebel D., Frassdorf J., Preckel B., Thamer V., Schlack W.Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology. 2002;96: 934-940.
37.
Tanaka K., Weihrauch D., Kehl F., et al. Mechanism of preconditioning by isoflurane in rabbits: a direct role for reactive oxygen species. Anesthesiology. 2002;97:1485-1490.
38.
Toller WG, Gross ER, Kersten JR, Pagel PS, Gross GJ, Warltier DCSarcolemmal and mitochondrial adenosine triphosphate-dependent potassium channels: mechanism of desflurane-induced cardioprotection. Anesthesiology . 2000;92: 1731-1739.
39.
Ismaeil MS, Tkachenko I., Gamperl AK, Hickey RF, Cason BAMechanisms of isoflurane-induced myocardial preconditioning in rabbits. Anesthesiology. 1999;90: 812-821.
40.
Raphael J., Rivo J., Gozal Y.Isoflurane-induced myocardial preconditioning is dependent on phosphatidylinositol-3-kinase/ Akt signalling. Br J Anaesth. 2005;95:756-763.
41.
Raphael J., Zuo Z., Abedat S., Beeri R., Gozal Y.Isoflurane preconditioning decreases myocardial infarction in rabbits via up-regulation of hypoxia inducible factor 1 that is mediated by mammalian target of rapamycin. Anesthesiology. 2008;108:415-425.
42.
Walker DM, Walker JM, Pugsley WB, Pattison CW, Yellon DMPreconditioning in isolated superfused human muscle. J Mol Cell Cardiol. 1995;27:1349-1357.
43.
Rezkalla SH, Kloner RAIschemic preconditioning and pre-infarction angina in the clinical arena. Nat Clin Pract Cardiovasc Med. 2004;1:96-102.
44.
Jenkins DP, Steare SE, Yellon DMPreconditioning the human myocardium: recent advances and aspirations for the development of a new means of cardioprotection in clinical practice. Cardiovasc Drugs Ther. 1995;9:739-747.
45.
Effect of nicorandil on coronary events in patients with stable angina: the Impact of Nicorandil in Angina (IONA) randomised trial. Lancet. 2002;359:1269-1275.
46.
Ono H., Osanai T., Ishizaka H., et al. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation. Am Heart J. 2004;148:E15.
47.
Bolli R.The role of sodium-hydrogen ion exchange in patients undergoing coronary artery bypass grafting. J Card Surg. 2003;18(Suppl 1):21-26.
48.
Schultz JE, Hsu AK, Gross GJMorphine mimics the cardio-protective effect of ischemic preconditioning via a glibenclamidesensitive mechanism in the rat heart. Circ Res. 1996;78: 1100-1104.
49.
Zhang Y., Irwin MG, Wong TMRemifentanil preconditioning protects against ischemic injury in the intact rat heart. Anesthesiology. 2004;101:918-923.
50.
Kukreja RC, Ockaili R., Salloum F., Xi L.Sildenafil-induced cardioprotection in rabbits. Cardiovasc Res. 2003;60:700-701.
51.
Kukreja RC, Salloum F., Das A., et al. Pharmacological preconditioning with sildenafil: basic mechanisms and clinical implications. Vascul Pharmacol. 2005;42:219-232.
52.
Kersten JR, Fleisher LAStatins: the next advance in cardioprotection? Anesthesiology . 2006;105:1079-1080.
53.
Elrod JW, Lefer DJThe effects of statins on endothelium, inflammation and cardioprotection. Timely Top Med Cardiovasc Dis. 2005;9:E20.
54.
Tomai F., De Paulis R., Penta de Peppo A., et al. Beneficial impact of isoflurane during coronary bypass surgery on troponin I release. G Ital Cardiol. 1999 ;29:1007-1014.
55.
Belhomme D. , Peynet J., Louzy M., Launay JM, Kitakaze M., Menasche P.Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation. 1999;100: 11340-11344.
56.
Julier K., da Silva R., Garcia C., et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology. 2003;98:1315-1327.
57.
De Hert SG, ten Broecke PW, Mertens E., et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology . 2002;97:42-49.
58.
De Hert SG, Cromheecke S., ten Broecke PW, et al. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology. 2003;99:314-323.
59.
De Hert SG, Van der Linden PJ, Cromheecke S., et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology. 2004;101:299-310.
60.
Guarracino F., Landoni G., Tritapepe L., et al. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study. J Cardiothorac Vasc Anesth. 2006;20:477-483.
61.
Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579-H588.
62.
Chiari PC, Bienengraeber MW, Pagel PS, Krolikowski JG, Kersten JR, Warltier DCIsoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology . 2005;102:102-109.
63.
Tsang A., Hausenloy DJ, Mocanu MM, Yellon DMPostconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res. 2004;95:230-232.
64.
Yang XM, Proctor JB, Cui L., Krieg T., Downey JM, Cohen MVMultiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol . 2004;44:1103-1110.
65.
Argaud L., Gateau-Roesch O., Raisky O., Loufouat J., Robert D., Ovize M.Postconditioning inhibits mitochondrial permeability transition. Circulation. 2005;111:194-197.
66.
Lucchinetti E., da Silva R., Pasch T., Schaub MC, Zaugg M.Anaesthetic preconditioning but not postconditioning prevents early activation of the deleterious cardiac remodelling programme: evidence of opposing genomic responses in cardioprotection by pre- and postconditioning . Br J Anaesth. 2005;95:140-152.
67.
Yellon DM, Hausenloy DJRealizing the clinical potential of ischemic preconditioning and postconditioning . Nat Clin Pract Cardiovasc Med. 2005;2:568-575.
68.
Krolikowski JG, Weihrauch D., Bienengraeber M., Kersten JR, Warltier DC, Pagel PSRole of Erk1/2, p70s6K, and eNOS in isoflurane-induced cardioprotection during early reperfusion in vivo. Can J Anaesth . 2006;53:174-182.
69.
Krolikowski JG, Bienengraeber M., Weihrauch D., Warltier DC, Kersten JR, Pagel PSInhibition of mitochondrial permeability transition enhances isoflurane-induced cardioprotection during early reperfusion: the role of mitochondrial KATP channels. Anesth Analg. 2005;101: 1590-1596.
70.
Weihrauch D. , Krolikowski JG, Bienengraeber M., Kersten JR, Warltier DC, Pagel PSMorphine enhances isoflurane-induced postconditioning against myocardial infarction: the role of phosphatidylinositol-3-kinase and opioid receptors in rabbits. Anesth Analg. 2005;101:942-949.
